Australia Markets open in 8 hrs 38 mins

Bionomics Limited (BNO.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0230-0.0010 (-4.17%)
At close: 03:40PM AEDT
Currency in AUD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 2.18
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 30.0740
52-week low 30.0230
50-day moving average 30.0303
200-day moving average 30.0484

Share statistics

Avg vol (3-month) 31.32M
Avg vol (10-day) 33.67M
Shares outstanding 51.35B
Implied shares outstanding 6N/A
Float 8916.48M
% held by insiders 16.40%
% held by institutions 148.96%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:1
Last split date 302 Mar 2004

Financial highlights

Fiscal year

Fiscal year ends 30 June 2022
Most-recent quarter (mrq)30 June 2022


Profit margin 0.00%
Operating margin (ttm)-290.62%

Management effectiveness

Return on assets (ttm)-18.40%
Return on equity (ttm)-41.64%

Income statement

Revenue (ttm)6.06M
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)1,722.20%
Gross profit (ttm)-9.94M
EBITDA -16.68M
Net income avi to common (ttm)-21.76M
Diluted EPS (ttm)-0.0010
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)33.56M
Total cash per share (mrq)0.03
Total debt (mrq)693.62k
Total debt/equity (mrq)1.22
Current ratio (mrq)12.46
Book value per share (mrq)0.02

Cash flow statement

Operating cash flow (ttm)-21.76M
Levered free cash flow (ttm)-11.89M